A Smart Visualized Phototherapy Switch: From NIR-I Imaging-Guided Photodynamic Therapy to NIR-II-Guided Photothermal Therapy for Enhanced Cascade Tumor Photoablation

Abstract

Imaging-guided phototherapy holds promise for precision cancer treatment. However, most photosensitizers have only a singular modality of photodynamic therapy (PDT) or photothermal therapy (PTT), which make their therapeutic efficacy severely limited by the hypoxic and complex tumor microenvironment (TME). In this article, we provide a smart platform design (BOD-D) based on a visualized light-triggered phototherapeutic switch for transforming cancer therapy from near-infrared (NIR)-I imaging-guided PDT to activatable NIR-II-guided PTT while releasing nitric oxide (NO) for gas therapy (GT). BOD-D releases native NIR one-region fluorescence signals in tumors, which is used to direct robust PDT for tumor killing. As PDT is administered, the decreasing oxygen content in TME becomes progressively insufficient to maintain its excellent cell-killing effect. Subsequently, light triggers the dissociation of NO in BOD-D, activating a photothermal agent BOD-T that emits NIR-II fluorescence, for subsequent PTT. Notably, not only the light-mediated therapeutic mechanism can be switched from NIR-I-guided PDT to NIR-II-guided PTT, but also the NO released during this process will be used for GT to sensitize the above PDT and PTT. Our study contributes to the design of intelligent photosensitizers for cascade tumor photoablation.

Keywords

gas therapy / NIR-I/II imaging / photodynamic therapy / phototherapy switch / photothermal therapy

References

[1] V. J. N. Bykov, S. E. Eriksson, J. Bianchi, and K. G. Wiman, “Targeting Mutant p53 for Efficient Cancer Therapy,” Nature Reviews Cancer 18 (2018): 89-102.

[2] Y. Wang, S. Xu, L. Shi, C. Teh, G. Qi, and B. Liu, “Cancer-Cell-Activated In Situ Synthesis of Mitochondria-Targeting AIE Photosensitizer for Precise Photodynamic Therapy,” Angewandte Chemie International Edition 60 (2021): 14945-14953.

[3] E. S. Reis, D. C. Mastellos, D. Ricklin, A. Mantovani, and J. D. Lambris, “Complement in Cancer: Untangling an Intricate Relationship,” Nature Reviews Immunology 18 (2018): 5-18.

[4] R. Li, Y. Huang, and J. Lin, “Distinct Effects of General Anesthetics on Lung Metastasis Mediated by IL-6/JAK/STAT3 Pathway in Mouse Models,” Nature Communications 11 (2020): 642.

[5] Z. Tang, Y. Liu, M. He, and W. Bu, “Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-Like Reactions,” Angewandte Chemie International Edition 58 (2019): 946-956.

[6] T. Gu, T. Chen, L. Cheng, X. Li, G. Han, and Z. Liu, “Mesoporous Silica Decorated With Platinum Nanoparticles for Drug Delivery and Synergistic Electrodynamic-Chemotherapy,” Nano Research 13 (2020): 2209-2215.

[7] E. Boros and A. B. Packard, “Radioactive Transition Metals for Imaging and Therapy,” Chemical Reviews 119 (2019): 870-901.

[8] C. Xu and K. Pu, “Second Near-Infrared Photothermal Materials for Combinational Nanotheranostics,” Chemical Society Reviews 50 (2021): 1111-1137.

[9] S. Liu, Y. Pei, Y. Sun, et al., ““Three Birds With One Stone” Nanoplatform: Efficient Near-Infrared-Triggered Type‑I AIE Photosensitizer for Mitochondria-Targeted Photodynamic Therapy Against Hypoxic Tumors,” Aggregate 5 (2024): e547.

[10] H. Li, Q. Yao, W. Sun, et al., “Aminopeptidase N Activatable Fluorescent Probe for Tracking Metastatic Cancer and Image-Guided Surgery via in Situ Spraying,” Journal of the American Chemical Society 142 (2020): 6381-6389.

[11] X. Mu, F. Wu, Y. Tang, et al., “Boost Photothermal Theranostics Via Self-Assembly-Induced Crystallization (SAIC),” Aggregate 3 (2022): e170.

[12] D. Xi, N. Xu, X. Xia, et al., “Strong π-π Stacking Stabilized Nanophotosensitizers: Improving Tumor Retention for Enhanced Therapy for Large Tumors in Mice,” Advanced Materials 34 (2022): 2106797.

[13] J.-C. Yang, L. Wu, L. Wang, et al., “An Efficient Photothermal Conversion Material Based on D-A Type Luminophore for Solar-Driven Desalination,” Aggregate 5 (2024): e535.

[14] J. Li, R. Jiang, Q. Wang, et al., “Semiconducting Polymer Nanotheranostics for NIR-II/Photoacoustic Imaging-Guided Photothermal Initiated Nitric Oxide/Photothermal Therapy,” Biomaterials 217 (2019): 119304.

[15] K. Wang, Y. Li, X. Wang, et al., “Gas Therapy Potentiates Aggregation-Induced Emission Luminogen-Based Photoimmunotherapy of Poorly Immunogenic Tumors Through cGAS-STING Pathway Activation,” Nature Communications 14 (2023): 2950.

[16] Q. Sun, Q. Su, Y. Gao, et al., “Cationic Telluroviologen Derivatives as Type-I Photosensitizers for Tumor Photodynamic Theranostics,” Aggregate 4 (2023): e298.

[17] V.-N. Nguyen, Y. Yan, J. Zhao, and J. Yoon, “Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer,” Accounts of Chemical Research 54 (2021): 207-220.

[18] W. Hu, X. Miao, H. Tao, et al., “Manipulating Nonradiative Decay Channel by Intermolecular Charge Transfer for Exceptionally Improved Photothermal Conversion,” ACS Nano 13 (2019): 12006-12014.

[19] D. Li, W. He, X. Lin, et al., “Enzyme-Free Photothermally Amplified Fluorescent Immunosorbent Assay (PAFISA) for Sensitive Cytokine Quantification,” Aggregate 4 (2023): e384.

[20] Y. Wang, T. Yang, and Q. He, “Strategies for Engineering Advanced Nanomedicines for Gas Therapy of Cancer,” National Science Review 7 (2020): 1485-1512.

[21] Z. Fang, J. Zhang, Z. Shi, et al., “A Gas/Phototheranostic Nanocomposite Integrates NIR-II-Peak Absorbing Aza-BODIPY With Thermal-Sensitive Nitric Oxide Donor for Atraumatic Osteosarcoma Therapy,” Advanced Materials 35 (2023): 2301901.

[22] H. Wang, Y. Wang, W. Xu, et al., “Host-Guest-Interaction Enhanced Nitric Oxide Photo-Generation Within a Pillar[5]arene Cavity for Antibacterial Gas Therapy,” ACS Applied Materials & Interfaces 15 (2023): 54266-54279.

[23] W.-L. Liu, T. Liu, A.-M. Cao, S.-Y. Qin, J. Feng, and X.-Z. Zhang, “Coordination Between Anti-Inflammation and Antitumor Actions for Systematic Tumor Treatments With Improved Prognosis,” Chemical Engineering Journal 439 (2022): 135711.

[24] Y. Wan, L. H. Fu, C. Li, J. Lin, and P. Huang, “Conquering the Hypoxia Limitation for Photodynamic Therapy,” Advanced Materials 33 (2021): 2103978.

[25] G. Gao, X. Sun, and G. Liang, “Nanoagent-Promoted Mild-Temperature Photothermal Therapy for Cancer Treatment,” Advanced Functional Materials 31 (2021): 2100738.

[26] G. Luo, Z. Li, M. Chen, et al., “Three-Staged Tumor Inhibition by Mitochondria-Targeted Cascaded Gas/Mild-Photothermal/Photodynamic Synergistic Therapy,” Chemical Engineering Journal 442 (2022): 136169.

[27] R. L. Flaherty, H. Intabli, M. Falcinelli, et al., “Stress Hormone-Mediated Acceleration of Breast Cancer Metastasis is Halted by Inhibition of Nitric Oxide Synthase,” Cancer Letters 459 (2019): 59-71.

[28] Y.-Y. Zhao, X. Zhang, Z. Chen, et al., “Supramolecular Phthalocyanine Assemblies-Enhanced Synergistic Photodynamic and Photothermal Therapy Guided by Photoacoustic Imaging,” Aggregate 5 (2024): e514.

[29] L. Zhang, A. Yang, C. Ruan, et al., “Copper-Nitrogen-Coordinated Carbon Dots: Transformable Phototheranostics From Precise PTT/PDT to Post-Treatment Imaging-Guided PDT for Residual Tumor Cells,” ACS Applied Materials & Interfaces 15 (2023): 3253-3265.

[30] H. Bian, D. Ma, X. Zhang, et al., “Tailored Engineering of Novel Xanthonium Polymethine Dyes for Synergetic PDT and PTT Triggered by 1064 nm Laser Toward Deep-Seated Tumors,” Small 17 (2021): 2100398.

[31] C. Ji, X. Zheng, S. Li, C. Liu, and M. Yin, “Perylenediimides With Enhanced Autophagy Inhibition for a Dual-Light Activatable Photothermal Gas Therapy,” ACS Applied Materials & Interfaces 15 (2023): 34427-34435.

[32] H. Shi, C.-F. Xiong, L.-J. Zhang, et al., “Light-Triggered Nitric Oxide Nanogenerator With High l -Arginine Loading for Synergistic Photodynamic/Gas/Photothermal Therapy,” Advanced Healthcare Materials 12 (2023): 2300012.

[33] H. Gu, W. Liu, H. Li, et al., “2,1,3-Benzothiadiazole Derivative AIEgens for Smart Phototheranostics,” Coordination Chemistry Reviews 473 (2022): 214803.

[34] J. Guan, C. Liu, C. Ji, et al., “NIR-II Perylene Monoimide-Based Photothermal Agent With Strengthened Donor-Acceptor Conjugation for Deep Orthotopic Glioblastoma Phototheranostics,” Small 19 (2023): 2300203.

[35] X. Xing, E. Pang, S. Zhao, et al., “Cisplatin-Appended BODIPY for Near Infrared II Fluorescent and Photoacoustic Imaging-Guided Synergistic Phototherapy and Chemotherapy of Cancer,” Chinese Chemical Letters 35 (2024): 108467.

[36] Y. Jiang and K. Pu, “Molecular Probes for Autofluorescence-Free Optical Imaging,” Chemical Reviews 121 (2021): 13086-13131.

[37] R. Wang, X. Gu, Q. Li, et al., “Aggregation Enhanced Responsiveness of Rationally Designed Probes to Hydrogen Sulfide for Targeted Cancer Imaging,” Journal of the American Chemical Society 142 (2020): 15084-15090.

[38] L. Sun, X. Dong, J. Gao, et al., “Precise Spatiotemporal Identification of Mitochondrial H₂S Fluctuations Through Exploiting an On-Demand Photoactivated Probe,” Analytical Chemistry 95 (2023): 14288-14296.

[39] D. Cao, Z. Liu, P. Verwilst, et al., “Coumarin-Based Small-Molecule Fluorescent Chemosensors,” Chemical Reviews 119 (2019): 10403-10519.

[40] Z. Zheng, J. Gao, R. Wang, et al., “Molecular Engineering of Luminogens for High-Integrity Imaging of Hydrogen Polysulfides via Activatable Aggregation-Induced Dual-Color Fluorescence,” ACS Nano 17 (2023): 22060-22070.

[41] L. Sun, X. Wang, R. Chen, et al., “Engineering Organelle-Specific Activatable Molecules for Ultra-Fast and Reliable In Situ Mapping of Subcellular Nitric Oxide,” Journal of Materials Chemistry B 12 (2024): 2304-2312.

[42] T. Zhu, N. Ren, X. Liu, et al., “Probing the Intracellular Dynamics of Nitric Oxide and Hydrogen Sulfide Using an Activatable NIR II Fluorescence Reporter,” Angewandte Chemie International Edition 60 (2021): 8450-8454.

[43] M. Liang, L. Liu, Y. Sun, et al., “Furan-Modified Thiadiazolo Quinoxaline as an Electron Acceptor for Constructing Second Near-Infrared Aggregation-Induced Emission Fluorophores for Beyond 1300 nm Fluorescence/Photoacoustic Imaging and Photothermal Therapy,” Aggregate 5 (2024): e458.

[44] B. Shi, N. Ren, L. Gu, et al., “Theranostic Nanoplatform With Hydrogen Sulfide Activatable NIR Responsiveness for Imaging-Guided On-Demand Drug Release,” Angewandte Chemie International Edition 58 (2019): 16826-16830.

[45] E. Feng, Y. Liu, S. Lv, et al., “Fine-Tuning Cu (II)-Induced Self-Assembly of Hydrophilic Cyanine Dyes for Enhanced Tumor Photothermal Therapy,” Advanced Functional Materials 32 (2022): 2209258.

[46] G. Xu, Q. Yan, X. Lv, et al., “Imaging of Colorectal Cancers Using Activatable Nanoprobes With Second Near-Infrared Window Emission,” Angewandte Chemie International Edition 57 (2018): 3626-3630.

[47] H. S. Jung, J. Han, H. Shi, et al., “Overcoming the Limits of Hypoxia in Photodynamic Therapy: A Carbonic Anhydrase IX-Targeted Approach,” Journal of the American Chemical Society 139 (2017): 7595-7602.

[48] G. Wan, B. Chen, L. Li, et al., “Nanoscaled Red Blood Cells Facilitate Breast Cancer Treatment by Combining Photothermal/Photodynamic Therapy and Chemotherapy,” Biomaterials 155 (2018): 25-40.

[49] J. Zou, P. Wang, Y. Wang, et al., “Penetration Depth Tunable BODIPY Derivatives for pH Triggered Enhanced Photothermal/Photodynamic Synergistic Therapy,” Chemical Science 10 (2019): 268-276.

[50] H. S. Jung, P. Verwilst, A. Sharma, J. Shin, J. L. Sessler, and J. S. Kim, “Organic Molecule-Based Photothermal Agents: An Expanding Photothermal Therapy Universe,” Chemical Society Reviews 47 (2018): 2280-2297.

[51] W. Sun, X. Zhao, J. Fan, J. Du, and X. Peng, “Boron Dipyrromethene Nano-Photosensitizers for Anticancer Phototherapies,” Small 15 (2019): 1804927.

[52] X. Zhao, S. Long, M. Li, et al., “Oxygen-Dependent Regulation of Excited-State Deactivation Process of Rational Photosensitizer for Smart Phototherapy,” Journal of the American Chemical Society 142 (2020): 1510-1517.

[53] X. Wei, C. Zhang, S. He, et al., “A Dual-Locked Activatable Phototheranostic Probe for Biomarker-Regulated Photodynamic and Photothermal Cancer Therapy,” Angewandte Chemie International Edition 61 (2022): e202202966.

[54] X. Liu, B. Shi, Y. Gao, et al., “Ultrabright Near-Infrared Fluorescent DNA Frameworks for Near-Single-Cell Cancer Imaging,” Nature Photonics 19 (2025): 79-88.

[55] M. Cui, D. Tang, H. Zhang, G. Liang, C. Xu, and H. Xiao, “NIR-II Fluorescent Nanotheranostics With a Switchable Irradiation Mode for Immunogenic Sonodynamic Therapy,” Advanced Materials 36 (2024): 2411328.

[56] X. Bao, S. Zheng, L. Zhang, et al., “Nitric-Oxide-Releasing aza-BODIPY: A New Near-Infrared J-Aggregate With Multiple Antibacterial Modalities,” Angewandte Chemie 134 (2022): e202207250.

[57] E. Y. Zhou, H. J. Knox, C. J. Reinhardt, G. Partipilo, M. J. Nilges, and J. Chan, “Near-Infrared Photoactivatable Nitric Oxide Donors With Integrated Photoacoustic Monitoring,” Journal of the American Chemical Society 140 (2018): 11686-11697.

[58] T. A. Grover, J. A. Ramseyer, and L. H. Piette, “Photolysis of Nitrosamines and Nitrosamides at Neutral pH: A Spin-Trap Study,” Free Radical Biology & Medicine 3 (1987): 27-32.

[59] K. Piech, T. Bally, A. Sikora, and A. Marcinek, “Mechanistic Aspects of the Oxidative and Reductive Fragmentation of N-Nitrosoamines: A New Method for Generating Nitrenium Cations, Amide Anions, and Aminyl Radicals,” Journal of the American Chemical Society 129 (2007): 3211-3217.

[60] J. Sun, X. Cai, C. Wang, et al., “Cascade Reactions by Nitric Oxide and Hydrogen Radical for Anti-Hypoxia Photodynamic Therapy Using an Activatable Photosensitizer,” Journal of the American Chemical Society 143 (2021): 868-878.

[61] Z. Zhang, J. Wu, Z. Shang, et al., “Photocalibrated NO Release From N-Nitrosated Napthalimides upon One-Photon or Two-Photon Irradiation,” Analytical Chemistry 88 (2016): 7274-7280.

RIGHTS & PERMISSIONS

2025 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.